N/A N=4,450 Effect of Behavioral Nudges on Serious Illness Conversation Documentation
Cancer
Primary: Number of High Risk Patients With Documentation of a Serious Illness Conversation (SIC) — 112; 136; 115; 179 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=10 Response Inhibition in Tourette Syndrome
Tourette Syndrome
Primary: Stop Signal Reaction Time (SSRT) — 249; 245 milliseconds — p=0.49
Phase 3 N=65 Furosemide vs. Placebo for Severe Antepartum Hypertension
Pre-Eclampsia · Hypertension in Pregnancy · Pregnancy Complications
Primary: Mean Systolic Blood Pressure During Hour After Study Drug — 147; 152 mmHg
N/A N=14 INtra-procedural ultraSound Imaging During Pulmonary Veins Isolation
Atrial Fibrillation
Primary: Measurement of Left Atrial (LA) Wall Thickness on ICE/IVUS Frames — 22.18; 23.15; 27.04; 27.09 percentage
N/A N=32 Transcervical Balloon Compared to Osmotic Dilators Prior to Surgical Abortion
Abortion, Second Trimester
Primary: Procedure Time — 22.4; 22.6 minutes
Phase 2 N=64 Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults
Pneumococcal Vaccines
Primary: Percentage of Participants Reporting Solicited Local Reactions Within 7 Days After Vaccination in Each Age Group — 56.3; 81.3; 81.3; 93.8 percentage of participants
Phase 2 N=29 Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)
Stress Disorders, Post-Traumatic
Primary: Change From Baseline in the Clinician-Administered PTSD Total Symptom Severity Score — 35.5; 33.8; -6.8; -10.3 Score on a Scale
N/A N=69 A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery
Opioid Use · Pain, Post Operative
Primary: Efficacy of the nCAP Signal Relief Patch in Affecting Perioperative Opioid Requirement — 82.1; 102.6 MME
N/A N=27 Inspiratory Muscle Rehabilitation in Children With Obesity
Pediatric Obesity
Primary: Number of Participants Who Complete Study Visit 3 — 12; 13 Participants
Phase 4 N=40 A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma
Asthma
Primary: Change From Baseline to Week 12 in Constant Work Rate Exercise Endurance Time - CWRET (Constant Work Rate Exercise Test) — 0.923; 1.742 Minutes
Phase 2 N=61 Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)
Photorefractive Keratectomy
Primary: Safety - Adverse Events Including Serious Adverse Events — 1; 1 Participants — p=1.000
Phase 3 N=454 A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
Primary: Overall Response Rate (ORR) Per International Myeloma Working Group Uniform Response Criteria (IMWG-URC) — 86.3; 82.5 percentage of participants — p=0.0666
Phase 2 N=20 Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa
Attention Deficit Hyperactivity Disorder
Primary: Change From Baseline in Total AISRS Score at the End of Double-blind Treatment (Week 8) — -17; -17 units on a scale
N/A N=50 Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer
Endometrial Cancer
Primary: Health Related Quality of Life (HRQoL) — 0.34; 0.30; 0.66; 0.48 scores on a scale — p=0.011
Phase 2 N=16 Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy
Acute Myeloid Leukemia
Primary: Complete Remission Rate — 36 percentage of participants